What Analysts Are Saying About Vertex Pharmaceuticals Stock
What Analysts Are Saying About Vertex Pharmaceuticals Stock
關於福泰製藥股票，分析人士都在說些什麼
Breaking Down Analyst Ratings: A Detailed Examination...15 analysts have expressed a variety of opinions on Vertex Pharmaceuticals (NASDAQ:VRTX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的一個季度中，有15名分析師對福泰製藥（納斯達克：VRTX）發表了各種觀點，提供了從看好到看淡的多樣化觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照，展示了情緒在過去30天中的演變情況，並將其與之前的月份進行比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $500.53, a high estimate of $600.00, and a low estimate of $376.00. Witnessing a positive shift, the current average has risen by 8.29% from the previous average price target of $462.20.
分析師評估的12個月價格目標揭示了更多見解，平均目標爲500.53美元，高估爲600.00美元，低估爲376.00美元。目前的平均目標已經出現正面變化，比上一次的平均價格目標462.20美元上漲了8.29%。
Breaking Down Analyst Ratings: A Detailed Examination...
分析師評級分析...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。